In rodent and human PAH PASMCs, adenoviral-mitofusin-2 (Ad-MFN2) overexpression led to a decrease in pulmonary vascular resistance and PA medial thickness, and an increase in lung vascularity [70]. The gene discussed is MFN2; the disease is pulmonary arterial hypertension.